These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32659433)

  • 21. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.
    Treister NS; Woo SB; O'Holleran EW; Lehmann LE; Parsons SK; Guinan EC
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):721-31. PubMed ID: 16125643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
    Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
    Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lichenoid sialadenitis in chronic graft versus host disease.
    Piacenza Florezi G; Monteiro de Souza M; Ducati Dabronzo ML; Batista Bologna S; Menta Simonsen M; Lourenço SV
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.
    Treister N; Chai X; Kurland B; Pavletic S; Weisdorf D; Pidala J; Palmer J; Martin P; Inamoto Y; Arora M; Flowers M; Jacobsohn D; Jagasia M; Arai S; Lee SJ; Cutler C
    Bone Marrow Transplant; 2013 Aug; 48(8):1123-8. PubMed ID: 23353804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic GVHD in minor salivary glands and oral mucosa: histopathological and immunohistochemical evaluation of 25 patients.
    Soares AB; Faria PR; Magna LA; Correa ME; de Sousa CA; Almeida OP; Cintra ML
    J Oral Pathol Med; 2005 Jul; 34(6):368-73. PubMed ID: 15946186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Chronic Graft-versus-Host Disease and Oral Health after Allogeneic Hematopoietic Cell Transplantation - What the Care Team Needs to Know.
    Laheij AMGA; Fregnani ER; de Macedo LD; Treister NS
    Transplant Cell Ther; 2024 Sep; 30(9S):S548-S558. PubMed ID: 39370236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of oral labial biopsy in hepatic graft-versus-host disease diagnosis in patients following allogeneic hematopoietic stem cell transplantation--a preliminary report.
    Prochorec-Sobieszek M; Nasiłowska-Adamska B; Szumera-Ciećkiewicz A; Tomaszewska A; Hałaburda K; Szczepiński A; Szymańska-Giemza O; Ziarkiewicz-Wróblewska B; Mariańska B
    Ann Transplant; 2012; 17(3):85-92. PubMed ID: 23018260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oral complications of allogeneic haematopoietic SCT.
    Hull KM; Kerridge I; Schifter M
    Bone Marrow Transplant; 2012 Feb; 47(2):265-70. PubMed ID: 21441960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients.
    Nicolatou-Galitis O; Kitra V; Van Vliet-Constantinidou C; Peristeri J; Goussetis E; Petropoulos D; Grafakos S
    J Oral Pathol Med; 2001 Mar; 30(3):148-53. PubMed ID: 11271629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral chronic graft-vs.-host disease characterization using the NIH scale.
    Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
    J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation.
    Pereira CM; de Almeida OP; Corrêa ME; Costa FF; de Souza CA; Barjas-Castro ML
    Oral Dis; 2007 May; 13(3):329-34. PubMed ID: 17448218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistopathological study of the oral lichenoid lesions of chronic GVHD.
    Sato M; Tokuda N; Fukumoto T; Mano T; Sato T; Ueyama Y
    J Oral Pathol Med; 2006 Jan; 35(1):33-6. PubMed ID: 16393251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral and Gut Microbiome Alterations in Oral Chronic GVHD Disease: Results from Close Assessment and Testing for Chronic GVHD (CATCH Study).
    Rashidi A; Pidala J; Hamilton BK; Pavletic SZ; Kim K; Zevin A; Mays JW; Lee SJ
    Clin Cancer Res; 2024 Sep; 30(18):4240-4250. PubMed ID: 39017661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature.
    Balasubramaniam R; Alawi F; DeRossi S
    Gen Dent; 2009; 57(1):82-8. PubMed ID: 19146147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria.
    Pengpis N; Prueksrisakul T; Chanswangphuwana C
    Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e167-e173. PubMed ID: 36173715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know.
    Haverman TM; Raber-Durlacher JE; Raghoebar II; Rademacher WMH; Rozema FR; Hazenberg MD; Epstein JB; Treister NS
    J Am Dent Assoc; 2020 Nov; 151(11):846-856. PubMed ID: 33121606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.
    Mays JW; Fassil H; Edwards DA; Pavletic SZ; Bassim CW
    Oral Dis; 2013 May; 19(4):327-46. PubMed ID: 23107104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.